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http://dxObjectives: The purpose of the present study was to evaluate the association of open and closed Fontan fenes-
tration status with event-free survival.
Methods: All patients who underwent a fenestrated Fontan procedure at our institution from January 1994
through June 2007 were reviewed. Patient information was obtained from the medical records. The patients
were assigned to 1 of 2 study groups, open or closed, according to their most recent fenestration status. Clinically
relevant morbid events were tabulated, and Kaplan-Meier event analysis was used to create event-free probabil-
ity curves with log-rank comparisons.
Results:A total of 161 patients were classified as open and 51 as closed. The median interval to an event was 1.1
years (interquartile range, 0.1-3.3 years) after the Fontan procedure. Themedian interval to closurewas 1.2 years
(interquartile range, 0.7-3.3 years). The median interval to an event was 1.5 years (interquartile range, 0.1-4.6
years) in the closed group and 1.1 years (interquartile range, 0.1-3.3 years) in the open group. Event-free prob-
ability analysis revealed no significant difference between the 2 groups (P¼ .15). The median follow-up arterial
oxygen saturation was greater in the closed group (96.0%; interquartile range, 94.0%-97.0%) than in the open
group (91.0%; interquartile range, 86.0%-95.0%; P<.0001).
Conclusions: Fenestration closure was associated with greater arterial oxygen saturation but not greater event-
free survival. The interval to an event was slightly less than the interval to fenestration closure, suggesting
potential merit in the evaluation of earlier fenestration closure. Adoption of specific fenestration management
guidelines might help improve the overall outcomes and enhance the quality of future studies. (J Thorac Cardi-
ovasc Surg 2013;145:183-7)C
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Fenestration of the Fontan circuit has been shown to improve
early outcomes, including a decreased duration and quantity
of chest tube drainage, a shorter duration ofmechanical ven-
tilation, and a shorter postoperative length of stay.1-5 Even in
the present era inwhich fenestration is applied selectively by
some groups, it continues to be used in high-risk patients,
such as those with hypoplastic left heart syndrome.
Although a benefit in the early postoperative period, Fon-
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The Journal of Thoracic and Cacyanosis and systemic thromboembolic events due to a per-
sistent right-to-left shunt combined with an increased risk
of thrombus formation due to venous stasis and hypercoag-
ulability. Alternatively, persistent fenestration might be
a benefit because the lower central venous pressure might
decrease the risk of exercise intolerance, protein-losing en-
teropathy (PLE), plastic bronchitis, and bradyarrhythmias.
The question of whether and when to intentionally close
a fenestration remains unanswered. Management protocols
have tended to vary, ranging from active fenestration clo-
sure at predetermined intervals to a ‘‘hands-off’’ approach
in which the natural history of fenestration status is allowed
to progress. A cross-sectional study of a large cohort of
Fontan patients by the Pediatric Heart Network found that
20% of patients had patent fenestrations at a median of
8.6 years after the Fontan procedure.6 Of those that were
closed at follow-up, approximately 50% had been closed
by active intervention (catheter based or surgical).
Therefore, we performed an analysis of a cohort of Fon-
tan patients to determine the association between fenestra-
tion status and morbid clinical events.METHODS
Subjects
The records of all patients who had undergone a fenestrated Fontan pro-
cedure at Children’s Hospital of Wisconsin from January 1994 through
June 2007 were reviewed. The patients were assigned to 1 of 2 studyrdiovascular Surgery c Volume 145, Number 1 183
Abbreviations and Acronyms
EFP ¼ event-free probability
IQR ¼ interquartile range
PLE ¼ protein-losing enteropathy
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Dgroups, open or closed, according to their most recent fenestration status as
assessed by echocardiography. The presence of a detectable shunt by echo-
cardiography, not the intervention history, determined the categorization as
open or closed. Of a total of 218 patients, 6 were excluded because of either
undifferentiated ventricular morphology (1 patient) or intraoperative con-
version to a nonfenestrated status at the original Fontan procedure (5
patients).
The human research review board at the Children’s Hospital of Wiscon-
sin authorized the collection of data from the existing medical records and
the waiver of the Health Insurance Portability and Accountability Act for
the present retrospective study.
Data Collection
The study participants were identified from the Herma Heart Center
Cardiology and Cardiothoracic Surgery database. Patient information
was obtained from the medical records, echocardiograms, cardiac catheter-
ization findings, and operative reports. De-identified patient information
was maintained using the REDCap web-based research data capture
application.
Fenestrated Fontan Technique
Fenestrations were routinely created in all patients undergoing the Fon-
tan procedure. Earlier in the study interval, certain patients were selected
for fenestration closure before leaving the operating room according to
the hemodynamics and echocardiographic findings. For most patients in
the present study (and routinely in the present era), the fenestrations
were left open. Our technique of performing the lateral tunnel or extracar-
diac fenestrated Fontan procedure has been previously described.7 For all
patients, a coronary punch was used to create a fenestration with a diameter
of 3.5 to 4.0 mm. For the lateral tunnel Fontan procedure, the fenestration
was placed at the center of the Gore-Tex polytetrafluoroethylene baffle
(WL Gore & Associates, Flagstaff, Ariz). For the extracardiac Fontan pro-
cedure, the atriotomy that results from detaching the inferior vena cava
from the right atrium was sewn to the Gore-Tex tube (WL Gore & Associ-
ates) as a large circle to centrally encompass the fenestration and prevent
the adjacent atrial wall from affecting the size of the fenestration. For the
extracardiac Fontan procedure, a fenestration pursestring suture and snare
(left open) were placed in an accessible subcutaneous pocket below the
sternotomy to permit subsequent potential closure of the snare and
fenestration.Fenestration Closure Technique
Our general approach was to evaluate patients for fenestration closure at
1 to 3 years after the Fontan procedure. The patients were brought to the
cardiac catheterization laboratory to first determine their suitability for
closure. The decision to close the fenestration was individualized for
each patient and was determined from a multidisciplinary assessment of
test closure-induced changes in systemic venous pressure, cardiac output,
and oxygen saturation. Closure was then completed during the same anes-
thetic session with echocardiographic and/or angiographic confirmation of
the closure. For most patients undergoing closure, the fenestration snare
was exposed through a limited skin incision, and the snare was closed
and secured with hemoclips. A few patients, including those with residual
shunts after attempted snare closure, underwent closure with an Amplatzer
septal occluder (AGA Medical, Golden Valley, Minn).184 The Journal of Thoracic and Cardiovascular SurgOutcome Variables
Morbid events after Fontan palliation were defined as death, transplan-
tation, Fontan takedown, New York Heart Association functional classifi-
cation III or IV, pacemaker placement, PLE, stroke, thrombus, plastic
bronchitis, subsequent thoracic surgery, or post-Fontanmechanical circula-
tory support. The interval during which a patient was free from an event
determined the event-free survival. Events (but not patients) were excluded
from the present analysis if they had occurred within 1 calendar day of the
Fontan procedure. Such events were regarded as being more related to the
overall impact of the surgical procedure and less to the fenestration. The
follow-up duration was calculated from the date of the Fontan procedure
to the last known clinical visit, if no events had occurred, or from the
date of the Fontan procedure to the date of an event.
Statistical Analysis
Descriptive characteristics of the sample are summarized using the me-
dian and interquartile range, because the variables were skewed. The
Wilcoxon-Mann-Whitney test was used to compare continuous variables
and the chi-square test or Fisher exact test to compare fenestration groups
(open vs closed) for patient characteristics. Kaplan-Meier survival analysis
was used to assess the event-free survival, withWilcoxon log-rank compar-
isons between the open and closed groups. All analyses were done in SAS,
version 9.2 (SAS Institute, Cary, NC).
RESULTS
Group Characteristics
Of the 212 patients in the present cohort, 161 were cate-
gorized as open and 51 as closed. Included in the open
group were 10 patients who had undergone fenestration clo-
sure interventions with subsequent echocardiographically
determined residual shunts and 19 patients who had under-
gone fenestration closure on the same day as their last
known clinical follow-up visit. Included in the closed group
were 18 patients with spontaneously closed fenestrations.
The patient characteristics are summarized in Table 1. No
significant differences were found in the patient character-
istics between the open and closed groups.
Themean andmedian duration of follow-up after the Fon-
tan procedure was 3.8 and 3.5 years (interquartile range
[IQR], 0.9-6.1 years) for the entire cohort, 3.1 and 2.4 years
(IQR, 0.7-4.9 years) for the open group, and 5.9 and 6.0 years
(IQR, 4.4-8.0 years) for the closed group, respectively. The
mean and median interval from Fontan to fenestration clo-
surewas 2.1 and 1.2 years (IQR, 0.7-3.3 years), respectively.
Events and Event-Free Probability
Of a total of 92 events, 72 occurred in the open group (50
of 161 patients, 31%) and 20 in the closed group (15 of 51
patients, 29%). In the closed group, 7 patients had events
before fenestration closure and 9 after fenestration closure.
The events are summarized according to closure status in
Table 2. The most notable differences between the open
and closed groups occurred with the event of New York
Heart Association class III or IV, which occurred in 16.8%
of the open compared with 2.0% of the closed group; and
the event of PLE, which occurred in 4.3% of the open group
compared with 0% in the closed group.ery c January 2013
TABLE 2. Event characteristics stratified by fenestration group
Event type Open
Closed
Cumulative
Before
closure
After
closure
Death 5 (3.1) 0 (0) 3 (5.9) 8 (3.8)
Heart transplantation 1 (0.6) 0 (0) 0 (0) 1 (0.5)
Fontan takedown 1 (0.6) 0 (0) 0 (0) 1 (0.5)
NYHA III or IV* 27 (16.8) 0 (0) 1 (2.0) 28 (13.2)
Pacemaker 7 (4.3) 1 (2.0) 1 (2.0) 9 (4.2)
PLE 7 (4.3) 0 (0) 0 (0) 7 (3.3)
Stroke 3 (1.9) 0 (0) 0 (0) 3 (1.4)
Thrombus 9 (5.6) 1 (2.0) 3 (5.9) 13 (6.1)
Plastic bronchitis 0 (0) 1 (2.0) 0 (0) 1 (0.5)
Subsequent thoracic surgery 11 (6.8) 5 (9.8) 3 (5.9) 19 (9.0)
ECMO 1 (0.6) 0 (0) 1 (2.0) 2 (0.9)
Total 72 (44.7) 8 (15.7) 12 (23.5) 92 (43.4)
Data presented as n (%). ECMO, Extracorporeal membrane oxygenation; NYHA,
New York Heart Association; PLE, protein-losing enteropathy. *Ten patients had un-
documented NYHA functional classification, 9 in the open group and 1 in the closed
group; for consistency, row percentages calculated using denominator of 161 for open
and 51 for closed groups.
TABLE 1. Patient characteristics
Characteristic Open Closed P value
Gender .11
Male 111 (68.9) 29 (56.9)
Female 50 (31.1) 22 (43.1)
Diagnosis category .84
Hypoplastic left heart syndrome 76 (47.2) 21 (41.2)
Double inlet left ventricle 28 (17.4) 12 (23.5)
Tricuspid atresia 19 (11.8) 8 (15.7)
Unbalanced atrioventricular canal 10 (6.2) 4 (7.8)
Heterotaxy 11 (6.8) 2 (3.9)
Pulmonary atresia with intact
ventricular septum
6 (3.7) 2 (3.9)
Other 11 (6.8) 2 (3.9)
Ventricular morphology .21
Left 60 (37.3) 24 (47.1)
Right 101 (62.7) 27 (52.9)
Fontan type .94
Lateral tunnel 37 (23.0) 12 (23.5)
Extracardiac 124 (77.0) 39 (76.5)
Age at Fontan (y) .80
Median 2.92 3.05
IQR 2.31-3.72 2.22-3.72
Weight at Fontan (kg) .49
Median 13.0 12.8
IQR 11.7-14.7 11.0-14.9
Data presented as n (%) or median and IQR. IQR, Interquartile range.
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interval to an event was 1.1 years (IQR, 0.1-3.3 years) for
the open group and 1.5 years (IQR, 0.1-4.6 years) for the
closed group. Figure 1 shows the EFP curves for the closed
and open groups. The closed group demonstrated a margin-
ally greater EFP; however, the difference was not statisti-
cally significant (P ¼ .08).
EFP calculated with intervals referenced to the time of
Fontan has the benefit of a longer period of follow-up.
Because the present analysis included events occurring
before fenestration closure in the group ultimately under-
going fenestration closure, it could not exclusively evalu-
ate the association of closed fenestration status with
events. In an effort to address this issue, an additional
analysis was completed, in which the median interval to
fenestration closure was selected as the reference point
for measuring the interval to an event. Therefore, the pa-
tients who had no follow-up subsequent to 424 days after
the Fontan procedure were excluded, and events (but not
patients) in both the open and the closed groups occurring
before 424 days after the Fontan procedure were excluded.
For the latter analysis, 47 patients were in the closed group
and 102 patients were in the open group. Figure 2 shows
the EFP curves for the open and closed groups, with no
significant difference found between the 2 groups
(P ¼ .15). For this comparison, the median length of
follow-up was 2.8 years (IQR, 1.6-5.1 years) for theThe Journal of Thoracic and Caopen group (increased because of skewness in the
follow-up interval distribution curve) and 5.0 years
(IQR, 3.6-6.9 years) for the closed group.
The only significant difference in outcome measures at
the latest follow-up visit was arterial oxygen saturation. In
a nonparametric comparison, the closed group had amedian
oxygen saturation of 96% (IQR, 94.0%-97.0%) compared
with 91.0% (IQR, 86.0%-95.0%) in the open group
(P<.0001).DISCUSSION
Our results contribute to the increasing, but incomplete,
knowledge pertaining to the management of Fontan fenes-
trations. The primary finding was that fenestration closure
in our cohort was not associated with improved event-free
survival, despite a probable influence of selection bias fa-
voring a greater event-free survival in the closed group. Se-
lection bias can be inferred by referring to Table 2—no
cases of New York Heart Association class III or IV oc-
curred before fenestration closure in the group that ulti-
mately underwent fenestration closure. In contrast, 27
cases (16.8%) of this event occurred in the open group dur-
ing a comparable follow-up interval. Furthermore, PLE was
present in 7 patients in the open group but 0 patients in the
closed group. It would be highly provocative to suggest that
a patent 4-mm fenestration might cause PLE, although it
would be consistent with clinical practice to withhold pa-
tients with PLE from referral for fenestration closure.
In general, our results are consistent with a recent report
of the Pediatric Heart Network in which no differences were
found between groups in terms of thromboembolic events,
exercise capacity, ventricular function, peak oxygen con-
sumption, and other measures of performance.6 The onlyrdiovascular Surgery c Volume 145, Number 1 185
FIGURE 1. Event-free probability curves comparing interval to event in
open and closed groups using date of Fontan procedure as time 0 for calcu-
lating event intervals.
FIGURE 2. Event-free probability curves comparing interval to event in
open and closed groups using median interval of fenestration closure as
time 0 for calculating event intervals (see text for explanation).
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8 points greater in patients with closed fenestrations. Other
reports have also shown no difference in maximum oxygen
consumption, with patients generally reaching 60% to 70%
of predicted values, and have highlighted the difficulties in
predicting what degree of benefit active fenestration man-
agement might provide.6,8-11 To date, other than the arterial
oxygen saturation, the only documented improvements (in
single reports) associated with fenestration closure have
been reduced ventilatory abnormalities with exercise and
a lower incidence of late tachyarrhythmias.10,12 Because
most patients in the present report, and in previous reports,
had not reached mid-adulthood, the longer term effect of
fenestration status on various outcome measures remains
unknown.
A second finding of our study was that fenestration clo-
sure was associated with a greater follow-up arterial oxy-
gen saturation. This is consistent with expectations and
what has been reported by others.6,9,10,13 Eliminating
cyanosis and potentially at least 1 impetus for ongoing
collateral formation and ineffectual cardiac output would
seem to be appropriate. However, as noted by others, the
long-term clinical relevance of increasing the oxygen sat-
uration from the high 80s to the mid-90s remains to be
verified.6,13
A potentially important finding of our study was that
median interval to an event was slightly less than the median
interval to fenestration closure—events occurred at a median
of 1.1 years in the overall cohort and fenestration closure oc-
curred at a median of 1.2 years. This suggests that earlier clo-
sure might be necessary to realize any potential benefit. We
are aware of 1 previous report by Goff and colleagues, in
which fenestration closure occurred at a median of 9 months
after the Fontan procedure.13 In their study, decompensation
after fenestration closure correlated with a shorter interval
from the Fontan procedure.13 However, their study compared
patients before and after fenestration closure and did not186 The Journal of Thoracic and Cardiovascular Surginclude a comparison group with patent fenestrations. In
our opinion, the potential benefit of fenestration closure
much earlier in the post-Fontan course remains an unresolved
issue.
At present, most available data (although limited)
provide no consistent basis for active fenestration closure
in all patients.6,8-13 Because fenestration closure has yet
to demonstrate efficacy for reducing stroke/systemic
embolization, the only apparent justification for closure
would seem to be clinically significant desaturation, based
more so on the secondary effects of cyanosis (not oxygen
delivery).6,14,15
The important question is whether the quality and mag-
nitude of the available data are sufficient to guide patient
treatment. The ongoing variation in management strate-
gies suggests that it is not. From our perspective, 3 options
could offer better insight on the issue of optimizing fenes-
tration management. Conducting a randomized controlled
trial, although theoretically appealing, would be limited
by several practical constraints. A second, and perhaps,
more practical option would be modeling the behavior
and performance of centers with superior long-term
outcomes of single-ventricle management. A third option
would be to adopt guidelines from the available evidence
that provide a set of management options from which
clinicians could agree to choose and consistently fol-
low—this might at least reduce the marked variability in
management strategies and enhance the quality of future
clinical studies.
Study Limitations
This was a retrospective study susceptible to various forms
of bias. In particular, clinicians might have avoided referring
for fenestration closure those patients with more concerning
clinical status. An additional limitation was the different
follow-up intervals of the 2 groups and the occurrence of sev-
eral events before fenestration closure in the closed group. Ofery c January 2013
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dian interval to fenestration closure as the reference point for
determining the interval to an event. For both EFP analyses,
the length of follow-up was relatively short and precluded
evaluation of any potential differences in longer term out-
comes. An additional issue was categorizing patients. Given
the institutional review board-governed time constraints, cer-
tain patients had no accessible follow-up after fenestration
closure. We believed the best method for managing this was
to categorize such patients in the open group. Also, certain
patients underwent attempted fenestration closure but
had residual shunts, and certain patients experienced spon-
taneous closure. It was our best judgment to categorize
these patients according to their physiologic status. We
performed additional analyses (not presented) with other
methods of categorization, and the results were similar.
However, we could not be certain that all possible methods
of categorization would produce similar results.
CONCLUSIONS
In the present cohort of fenestrated Fontan patients, fen-
estration closurewas associated with greater arterial oxygen
saturation but not greater event-free survival. In the overall
cohort, the median interval to an event was somewhat
shorter than the median interval to fenestration closure, sug-
gesting potential merit in the evaluation of earlier fenestra-
tion closure. Collaborative learning from centers with
superior long-term outcomes of single-ventricle manage-
ment and the adoption of specific fenestration management
guidelines might help improve overall outcomes and en-
hance the quality of future studies.
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